Important Changes at the Intersection of Antitrust and Administrative Law
The Federal Trade Commission and the Antitrust Division of the U.S. Department of Justice will soon publish new joint guidelines applicable to mergers that raise horizontal issues in the same market and to mergers that raise vertical issues in the same supply chain.
National Academies Workshop on Methadone Regulations
A recent National Academies workshop on the federal rules governing methadone treatment explored how these rules restrict patient access to life-saving treatment for opioid use disorder. As the overdose epidemic rages on, these regulations need an overhaul. Recent research from the Regulatory Studies Center, with support from the Pew Charitable Trusts, sheds light on promising pathways for reform.
EPA's New Science Advisory Process
EPA’s new process for engaging its science advisors would embed them in every step of the rulemaking process, which risks diminishing the independence of their review and possibly foreclosing consideration of important research, perspectives, and policy options.
Notice and Comment Policymaking During Uncertain Times
The notice and comment process—in which governments make public draft policies and solicit feedback on these proposals—is seen as a vehicle for promoting transparency, participation, and responsiveness in policymaking.
Comparing Regulatory Uncertainty with Other Policy Uncertainty Measures
Economic research shows that increased uncertainty can lead to significant reductions in hiring, investment, consumption, and output in the economy. Among many types of uncertainty, policy uncertainty has gained increased attention during recent years.
2021 was an...interesting year to say the least! The GW Regulatory Studies Center stayed busy producing dozens of essays on a wide array of topics in regulatory policy. This page highlights the top ten most viewed essays from our own website.
Vaccine Mandates and Roads Not Taken
Earlier this month, a six-justice majority of the U.S. Supreme Court stayed the vaccinate-or-test mandate that the Occupational Safety and Health Administration (OSHA) imposed on employers that have more than 100 employees.
What the Supreme Court’s Rejection of the Employer Vaccinate-or-Test Rule Means for Biden’s Agenda
The Biden administration’s pandemic response strategy suffered a setback on Jan. 13. The Supreme Court handed down a rushed decision that stayed a workplace safety rule issued by the Occupational Safety and Health Administration (OSHA) in November 2021.
Regulatory Policies and the Biden Administration
Last month, the Office of Information and Regulatory Affairs released its semiannual Unified Agenda of Regulatory and Deregulatory Actions. The documents lay out a priority set for the Biden administration as it enters into its second year.
One Year On, a Critical Role Needs to Be Filled By the Administration
President Biden has made regulation a priority during his first year in office. On Day One, he carried through on campaign promises and signed several executive orders, memorandums and directives charging agencies to reverse much of his predecessor’s actions and to “modernize” regulatory review. Since then, he has also aggressively pursued new regulatory priorities, including those related to racial equity, climate change, employment, and the pandemic.
